Enhanced antibacterial activity of antimicrobial peptide-antibiotic combinations against multidrug-resistant bacteria

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Multidrug-resistant (MDR) bacteria pose a significant global health threat, diminishing conventional antibiotic effectiveness.
• Antimicrobial peptides (AMPs) offer potential as adjunctive therapies due to their membrane-targeting and immunomodulatory actions, but face limitations in monotherapy.
• Combining AMPs with existing antibiotics is a promising approach to combat MDR infections.

Purpose of the Study:

• To critically review the mechanistic basis of AMP-antibiotic synergy against MDR bacteria.
• To identify key factors influencing synergistic outcomes and translational barriers.
• To provide a framework for optimizing AMP-antibiotic combination therapies.

Main Methods:

• Integration of evidence from in vitro and in vivo studies.
• Analysis of mechanistic determinants of synergy, including membrane permeability and porin-dependent uptake.
• Examination of host-related factors and resistance adaptations.

Main Results:

• Synergistic outcomes are governed by membrane permeability, porin-dependent antibiotic uptake, and resistance adaptations.
• Host factors not captured in vitro play a role in therapeutic success.
• Translational challenges include immune modulation, pharmacokinetic issues, peptide instability, and strain variability.

Conclusions:

• AMP-antibiotic combinations offer a rational strategy to enhance antibacterial efficacy against MDR pathogens.
• Understanding mechanistic determinants and translational barriers is crucial for clinical implementation.
• Further research is needed to optimize combination therapies for effective treatment of MDR bacterial infections.